Former CEO, Cambridge Antibodies (CAT) and Kymab; Non-Executive Chairman, IGEM Therapeutics; Board Member of Bond 2 Development 2 GP
Read More
President and CEO, Mass General Brigham; Laurie Carrol Guthart Professor of Medicine, Harvard Medical School
Read More
Chief Business Officer and Chief Financial Officer, Entasis Therapeutics
Read More
Former President and co-CEO, United Therapeutics
Read More
Former Senior Vice President, Head of North America, Rare Diseases, Genzyme, a Sanofi Company
Read More
Former CFO, Tom’s of Maine; Board of Trustees, Allianz Global Investors
Read More
President and Chief Executive Officer
Read More
